Orforglipron studies: 56 papers with results
Page 2 of 2
- Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis.
Alper A · High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
Not a test of Orforglipron alone · 7 results
- Predicting the Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN-1 Trial.
Shinde S · Diabetes, obesity & metabolism · 2026
Not a test of Orforglipron alone · 5 results
- Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor.
Cong Z · Nature communications · 2021
Not a test of Orforglipron alone · 3 results
- Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review.
Alsaqaaby MS · The lancet. Diabetes & endocrinology · 2024
Not a test of Orforglipron alone · 6 results
- Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete-Choice Experiment (OPTIC).
Almandoz JP · Diabetes, obesity & metabolism · 2026
Not a test of Orforglipron alone · 4 results
- Positive modulation of glucagon-like peptide 1 (GLP-1) receptor by endogenous haemorphins with implications in glucose metabolism and diabetes.
Khan FB · British journal of pharmacology · 2026
Not a test of Orforglipron alone · 1 result